Chinese equities ‘is the trade to do for the next six months’

China’s latest stimulus package, aimed at reviving its economy, could trigger a significant rally in equities over the next six months, according to renowned China watcher Louis-Vincent Gave, managing director and co-founder of Hong Kong-based Gavekal Research. “I believe it’s the trade to do for the next six months.”

Lagarde unintentionally reveals a glimpse behind the ECB-scene

Naturally, the interest rate decision and everything surrounding it took centre stage earlier this month when the European Central Bank (ECB) board met in Frankfurt. And of course, questions during the press conference focused on what we can expect in the coming quarters. Like many others, I was tuned in, eager for insights.

NAV errors: Tighter control, clearer guidance seek to improve fund valuations

Luxembourg’s financial watchdog, the CSSF, has made important changes to its rules for valuations of investment funds, the first in two decades. While many things stay the same, some key updates—like lowering limits for money market funds and adding new checks before making investment decisions—are aimed at tightening control and providing clearer guidance.

Morgan Stanley banker Albuquerque faces scrutiny as EU finance chief

Former Portuguese finance minister and Morgan Stanley banker Maria Luís Albuquerque, known for her austerity-heavy tenure during the eurozone crisis, is now the European Commission’s nominee for the influential role of Commissioner for Financial Services. Her appointment has already ignited controversy.

Fund Radar: Pharma companies regain their growth trajectory

Pharmaceutical companies were once known for their strong growth potential, but slowing revenue growth, lower valuations, and higher dividend yields have given them a more mixed profile in recent years. However, over the past three years, Novo Nordisk and Eli Lilly have stood out by reclaiming their growth status.